Abstract
A comprehensive update of the 2005 edition
The report estimates that the current market for addiction disorders is valued
at US$3.2 billion and this is forecast to increase 19% to US$3.8 billion by
2016.
Examines the market for addiction pharmacotherapies currently estimated at
US$2 billion
The substance dependence field is transforming into a high-growth market
opportunity. Supported by the success of Pfizer' s recently launched
Chantix/Champix, which is on track for blockbuster status in the smoking
cessation sector, pharmacotherapies in development for alcohol, narcotic, and
nicotine dependencies are poised to radically change the addiction treatment
landscape in this difficult-to-treat patient population.
The report estimates that the current market for addiction disorders is valued
at US$3.2 billion and this is forecast to increase 19% to US$3.8 billion by
2016.
The World Market for Addiction Disorders, 2009 2016: Future Therapies for
Substance Dependence and Impulse Control, will introduce the reader a
specialty pharmaceutical market which is positioned for high-growth based on
analysis of marketed and pipeline drugs, company activities, and addiction
disorder demographics.
Therapy area forecasting and illustrative comparative sales data is presented
to gain insight into leading products with sales estimates to 2016.
Objectives of Report
The objectives of this 80 page report are to provide an in-depth analysis of
the global addiction pharmacotherapeutic market. Included in this study are
analyses of key therapy areas, R&D programs, and innovating companies and
products. The reader will benefit from market forecasts, pooled knowledge of
recent industrial activities and events, and from analytical discourse, which
is intended to stimulate growth and create new market opportunities.
Report Highlights Include:
- The current market for addiction disorders is valued at US$3.2 billion, up
from US$2 billion in 2005
- Critical analysis of alcohol, cocaine, opiate, and nicotine addictions
- Review of epidemiological, aetiological, and demographic data for
addiction disorders
- Analysis of over 10 key marketed products and inclusion of 34 R&D
candidates identified in preclinical to clinical stages of development for
addiction disorders
- Sales estimates (US$) to 2012 for major therapy areas
- Strategic insights for life-cycle optimization and product development
- Critical evaluation of leading addiction pharmacotherapies
- Emerging markets identified and sector analysis
- Trend analysis of industry events and activities over past 2 years
- Detailed R&D themes and clusters by addiction area
- Data generation on sector and market values between 2004 and 2012 and
therapy forecasts by 2020 (US$)
- High revenue-yielding prospects identified with projected sales estimations
- R&D pipeline positioning for novel candidates
- Market insights for product development and drug promotion
What you can learn from this report:
- Which addiction therapies are the current and potential future market
leaders
- How companies are reformulating products for addiction indications
- Which premarket addiction pharmacotherapies are identified as high-value
products
- Which companies are developing drugs for addiction disorders
- Sales predictions to 2016 for addiction pharmacotherapies
- What the likely impact of pipeline products will be on value growth of the
addiction market over the 10 years
- Which addiction subsectors could be niche market opportunities
- What the future outlook holds for addiction pharmacotherapies
- Insight into R&D trends for alcohol, cocaine, opiate, and nicotine
addictions
- Which molecules and compounds are main R&D clusters for dependency
disorders
- Which of the pipeline candidates are top prospects in the addiction market
over the next decade and to 2025
Report Contains:
- Detailed survey and analysis of the current and future global addiction
disorder market
- Comprehensive update on key marketed products indicated for alcohol,
narcotic, and nicotine dependency disorders
- Review of epidemiological, demographic, aetiological, and therapeutic data
associated with addiction disorders
- Market analysis and insight of key addiction pharmacotherapies and
pipelines
- Market value predictions of individual marketed products to 2016
- Insight and trend analysis of pipeline products for addiction disorders
- Review of promising pipeline products and potential market opportunities
- Extensive coverage of the R&D pipeline for addiction disorders
- Guide to leads for potential licensing opportunities
| 
View Cart
